IDH3A and neoplasm: In the same year, Kim et al. (41) proposed a method using diffusion and perfusion-weighted MRI radiomics models to predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse low-grade gliomas.